Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 14, 2016; 22(26): 6065-6075
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6065
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6065
Figure 1 Patient flow.
Ninety-six out of the 693 patients screened were found to be eligible. HPB: Hepato-pancreato-biliary cancer; Jan: January; Pts: Patients.
Figure 2 Graphical representation of each of the patient’s follow-up included in this study, time on chemotherapy, and time of radiological progression and development of a stent-related event.
Figure 3 Kaplan Meier graphic.
Overall survival and type of stent-related event (SRE)-related consequence [mild (none/chemotherapy delayed) vs severe (chemotherapy interrupted/death)].
- Citation: Lamarca A, Rigby C, McNamara MG, Hubner RA, Valle JW. Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy. World J Gastroenterol 2016; 22(26): 6065-6075
- URL: https://www.wjgnet.com/1007-9327/full/v22/i26/6065.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i26.6065